ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Instrumentation

Agilent to acquire cell-analysis firm BioTek for $1.1 billion

by Michael McCoy
July 12, 2019 | APPEARED IN VOLUME 97, ISSUE 28

Agilent Technologies has agreed to acquire BioTek Instruments for a net price after tax benefits of about $1.05 billion. Based in Winooski, Vermont, BioTek produces cell-imaging systems, microplate readers, washers, and other tools for live cell analysis. It had sales last year of $162 million. Agilent entered the cell-analysis business in 2015 with the purchase of Seahorse Bioscience and later acquired two other firms in the field.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment